Atrial fibrillation aggravated and Subretinal haematoma

Summary:

Subretinal haematoma is reported only by a few people with Atrial fibrillation aggravated.

The study analyzes which people have Subretinal haematoma with Atrial fibrillation aggravated. It is created by eHealthMe based on 2 people who have Subretinal haematoma and Atrial fibrillation aggravated from the Food and Drug Administration (FDA), and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 12, 2022

2 people who have Atrial Fibrillation Aggravated and Subretinal Haematoma are studied.


What is Atrial fibrillation aggravated?

Atrial fibrillation aggravated (serious fibrillation of the muscles of the atria of the heart) is found to be associated with 1,157 drugs and 594 conditions by eHealthMe.

What is Subretinal haematoma?

Subretinal haematoma (localized collection of blood outside the blood vessels, usually in liquid form within the tissue of eyes) is found to be associated with 15 drugs and 9 conditions by eHealthMe.

Number of Subretinal haematoma in Atrial fibrillation aggravated reports submitted per year:

Would you have Subretinal haematoma when you have Atrial fibrillation aggravated?

Gender of people who have Atrial Fibrillation Aggravated and experienced Subretinal Haematoma *:

  • female: 50 %
  • male: 50 %

Age of people who have Atrial Fibrillation Aggravated and experienced Subretinal Haematoma *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common co-existing conditions for these people *:

  1. Arrhythmias (irregular heartbeat): 1 person, 50.00%
  2. Age-Related Macular Degeneration: 1 person, 50.00%

Common drugs taken by these people *:

  1. Xarelto: 1 person, 50.00%
  2. Clopidogrel: 1 person, 50.00%

Common symptoms for these people *:

  1. Subcutaneous Haematoma (collection of blood outside the blood vessels on the skin): 1 person, 50.00%
  2. Retinal Haemorrhage (bleeding from retina): 1 person, 50.00%
  3. Retinal Detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue): 1 person, 50.00%
  4. Overdose: 1 person, 50.00%
  5. Eye Irritation: 1 person, 50.00%
  6. Blindness Unilateral: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Subretinal haematoma?

Check whether Subretinal haematoma is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Subretinal haematoma:

All the drugs that are associated with Subretinal haematoma:

All the conditions that are associated with Subretinal haematoma:

How the study uses the data?

The study is based on Subretinal haematoma and Atrial fibrillation aggravated, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: